» Articles » PMID: 30170004

DNA Methylation As a Transcriptional Regulator of the Immune System

Overview
Journal Transl Res
Publisher Elsevier
Specialty Pathology
Date 2018 Sep 1
PMID 30170004
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

DNA methylation is a dynamic epigenetic modification with a prominent role in determining mammalian cell development, lineage identity, and transcriptional regulation. Primarily linked to gene silencing, novel technologies have expanded the ability to measure DNA methylation on a genome-wide scale and uncover context-dependent regulatory roles. The immune system is a prototypic model for studying how DNA methylation patterning modulates cell type- and stimulus-specific transcriptional programs. Preservation of host defense and organ homeostasis depends on fine-tuned epigenetic mechanisms controlling myeloid and lymphoid cell differentiation and function, which shape innate and adaptive immune responses. Dysregulation of these processes can lead to human immune system pathology as seen in blood malignancies, infections, and autoimmune diseases. Identification of distinct epigenotypes linked to pathogenesis carries the potential to validate therapeutic targets in disease prevention and management.

Citing Articles

The intersection of epigenetics and immune thrombocytopenia: new insights into disease mechanisms and treatments.

Zhou X, Shan N Mol Biol Rep. 2025; 52(1):257.

PMID: 39982580 DOI: 10.1007/s11033-025-10363-z.


Synthesizing unmodified, supercoiled circular DNA molecules .

Rezaei S, Moncada-Restrepo M, Leng S, Chambers J, Leng F bioRxiv. 2025; .

PMID: 39896529 PMC: 11785245. DOI: 10.1101/2025.01.24.634800.


Exploring changes in social spider DNA methylation profiles in all cytosine contexts following infection.

Fisher D, Bechsgaard J, Bilde T Heredity (Edinb). 2024; 133(6):410-417.

PMID: 39266675 PMC: 11589119. DOI: 10.1038/s41437-024-00724-y.


Pan-cancer exploration of PNO1: A prospective prognostic biomarker with ties to immune infiltration.

Qin Y, Li Z, Zhang X, Li J, Teng Y, Zhang N Heliyon. 2024; 10(17):e36819.

PMID: 39263087 PMC: 11387552. DOI: 10.1016/j.heliyon.2024.e36819.


Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy.

Xia X, Yang Z, Lu Q, Liu Z, Wang L, Du J Mol Cancer. 2024; 23(1):175.

PMID: 39187850 PMC: 11346058. DOI: 10.1186/s12943-024-02079-8.


References
1.
Bird A . DNA methylation patterns and epigenetic memory. Genes Dev. 2002; 16(1):6-21. DOI: 10.1101/gad.947102. View

2.
Del Campo R, Martinez E, Del Fresno C, Alenda R, Gomez-Pina V, Fernandez-Ruiz I . Translocated LPS might cause endotoxin tolerance in circulating monocytes of cystic fibrosis patients. PLoS One. 2012; 6(12):e29577. PMC: 3247277. DOI: 10.1371/journal.pone.0029577. View

3.
Abdel-Wahab O, Mullally A, Hedvat C, Garcia-Manero G, Patel J, Wadleigh M . Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood. 2009; 114(1):144-7. PMC: 2710942. DOI: 10.1182/blood-2009-03-210039. View

4.
Azad N, Zahnow C, Rudin C, Baylin S . The future of epigenetic therapy in solid tumours--lessons from the past. Nat Rev Clin Oncol. 2013; 10(5):256-66. PMC: 3730253. DOI: 10.1038/nrclinonc.2013.42. View

5.
Silverman L, Demakos E, Peterson B, Kornblith A, Holland J, Odchimar-Reissig R . Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B. J Clin Oncol. 2002; 20(10):2429-40. DOI: 10.1200/JCO.2002.04.117. View